ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, when only one or two copies of BCR-ABLp210 are expressed from the endogenous promoter in the Bcr locus, transgenic BCR-ABL animals do not develop CML during their entire lifetime [42•].